136 related articles for article (PubMed ID: 15715193)
1. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant.
Sadowska AM; van Overveld FJ; Górecka D; Zdral A; Filewska M; Demkow UA; Luyten C; Saenen E; Zielinski J; De Backer WA
Respir Med; 2005 Feb; 99(2):241-9. PubMed ID: 15715193
[TBL] [Abstract][Full Text] [Related]
2. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
[TBL] [Abstract][Full Text] [Related]
3. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation.
Loppow D; Schleiss MB; Kanniess F; Taube C; Jörres RA; Magnussen H
Respir Med; 2001 Feb; 95(2):115-21. PubMed ID: 11217907
[TBL] [Abstract][Full Text] [Related]
4. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Lung; 2006; 184(4):217-22. PubMed ID: 17006748
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis.
Balfour-Lynn IM; Klein NJ; Dinwiddie R
Arch Dis Child; 1997 Aug; 77(2):124-30. PubMed ID: 9301350
[TBL] [Abstract][Full Text] [Related]
6. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.
Culpitt SV; Maziak W; Loukidis S; Nightingale JA; Matthews JL; Barnes PJ
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1635-9. PubMed ID: 10556133
[TBL] [Abstract][Full Text] [Related]
7. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
Paggiaro PL; Dahle R; Bakran I; Frith L; Hollingworth K; Efthimiou J
Lancet; 1998 Mar; 351(9105):773-80. PubMed ID: 9519948
[TBL] [Abstract][Full Text] [Related]
8. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
9. Influence of different dosage schedules of inhaled fluticasone propionate on peripheral blood cytokine concentrations in childhood asthma.
Visser MJ; Postma DS; Brand PL; Arends LR; Duiverman EJ; Kauffman HF
Clin Exp Allergy; 2002 Oct; 32(10):1497-503. PubMed ID: 12372131
[TBL] [Abstract][Full Text] [Related]
10. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
[TBL] [Abstract][Full Text] [Related]
11. Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Rousseau R;
BMC Pulm Med; 2006 Feb; 6():3. PubMed ID: 16460562
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease.
Yildiz F; Kaur AC; Ilgazli A; Celikoglu M; Kaçar Ozkara S; Paksoy N; Ozkarakaş O
Respiration; 2000; 67(1):71-6. PubMed ID: 10705266
[TBL] [Abstract][Full Text] [Related]
13. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
Currie GP; Syme-Grant NJ; McFarlane LC; Carey FA; Lipworth BJ
Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD.
Perng DW; Tao CW; Su KC; Tsai CC; Liu LY; Lee YC
Eur Respir J; 2009 Apr; 33(4):778-84. PubMed ID: 19129278
[TBL] [Abstract][Full Text] [Related]
15. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
Schermer T; Chavannes N; Dekhuijzen R; Wouters E; Muris J; Akkermans R; van Schayck O; van Weel C
Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505
[TBL] [Abstract][Full Text] [Related]
16. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis.
Tsang KW; Ho PL; Lam WK; Ip MS; Chan KN; Ho CS; Ooi CC; Yuen KY
Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996
[TBL] [Abstract][Full Text] [Related]
17. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Gan WQ; Rousseau R;
Am J Respir Crit Care Med; 2008 Jun; 177(11):1207-14. PubMed ID: 18310480
[TBL] [Abstract][Full Text] [Related]
18. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.
Bourbeau J; Christodoulopoulos P; Maltais F; Yamauchi Y; Olivenstein R; Hamid Q
Thorax; 2007 Nov; 62(11):938-43. PubMed ID: 17557771
[TBL] [Abstract][Full Text] [Related]
19. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.
Lapperre TS; Snoeck-Stroband JB; Gosman MM; Jansen DF; van Schadewijk A; Thiadens HA; Vonk JM; Boezen HM; Ten Hacken NH; Sont JK; Rabe KF; Kerstjens HA; Hiemstra PS; Timens W; Postma DS; Sterk PJ;
Ann Intern Med; 2009 Oct; 151(8):517-27. PubMed ID: 19841453
[TBL] [Abstract][Full Text] [Related]
20. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK;
Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
